Market Misses Upside on Merck

Strong third-quarter results and better sales for cancer and hepatitis C drugs suggest Merck’s rise could continue.

Popular Posts


EOF

(Visited 2 times, 1 visits today)

Vote on this story -->>>


this is a single

THE MIAMI METROPOLIS -your source for news, music, sports, movies, restaurants, reviews, weather, travel, arts, tech and events in Miami